Biologics for chronic rhinosinusitis with nasal polyps: a real-world prospective cohort study. | Synapse
April 18, 2026
Biologics for chronic rhinosinusitis with nasal polyps: a real-world prospective cohort study.
Puntos clave
The study aims to assess the real-world efficacy of biologics in treating chronic rhinosinusitis with nasal polyps (CRSwNP).
Conducted a real-world prospective cohort analysis
Included patients with severe chronic rhinosinusitis with nasal polyps
Evaluated the clinical benefits of three registered biologics
Significant clinical benefit observed with all three biologics
Larger improvements noted in patients treated with dupilumab
Resumen
In this real-world cohort, the three registered biologics provided significant clinical benefit in severe CRSwNP, with numerically larger improvements observed in patients treated with dupilumab.